Inês Martins, PhD, managing science editor —

Patients with small-vessel vasculitides, including ANCA-associated vasculitis, are more likely to need aggressive treatments or to die in the intensive care unit (ICU) than patients with other systemic autoimmune diseases, a Polish study has found. However, after discharge from the ICU, mortality rates are similar for both groups of patients,…

Patients with ANCA-associated vasculitis (AAV) are more likely to exhibit severe disease and experience poor kidney outcomes if they have low levels of the C3 complement protein at diagnosis, a study found. Researchers said the findings will help doctors identify AAV patients with severe disease and select appropriate treatment at…

The Rare Autoimmune Rheumatic Diseases Alliance (RAIRDA) recently published a report highlighting the obstacles to diagnosis, treatment, and lifestyle experienced by people with rare autoimmune rheumatic diseases, like anti-neutrophil cytoplasmic autoantibody (ANCA) vasculitis, or AAV. The report, titled “Reduce, Improve, Empower,” was published Feb. 28, 2018, to…

Physicians, specialists, patients and families touched by vasculitis nationwide and around the world gathered June 23 at the Vasculitis Foundation’s 2017 International Vasculitis Symposium in Chicago. “Physicians and patients around the world have been looking to us for education and support for…